Cavendish University School of Medicine, Lusaka, Zambia.
Influenza Division, Centers for Disease Control and Prevention, Atlanta, USA.
Influenza Other Respir Viruses. 2018 Jan;12(1):46-53. doi: 10.1111/irv.12492. Epub 2017 Dec 15.
Estimates of influenza-associated hospitalization are limited in low- and middle-income countries, especially in Africa.
To estimate the national number of influenza-associated severe acute respiratory illness (SARI) hospitalization in Zambia.
We conducted active prospective hospital-based surveillance for SARI at the University Teaching Hospital (UTH) situated in Lusaka Province during 2011-2014. Upper respiratory tract samples were tested for influenza virus using a reverse transcriptase polymerase chain reaction assay. We estimated age-specific rates of influenza-associated SARI hospitalizations for the UTH using census and secondary data on respiratory hospitalizations following estimation approaches recommended by the World Health Organization. We used the UTH hospitalization rates as a proxy for Lusaka Province. These rates were adjusted for each of the remaining 9 provinces based on their prevalence of risk factors for pneumonia and healthcare-seeking behavior. Rates were expressed per 100,000 population.
SARI cases accounted for 77.1% (13 389/17 354) of respiratory admissions at the UTH; 82.7% (11 859/14 344) and 50.8% (1530/3010) among individuals aged <5 and ≥5 years, respectively. Among SARI cases tested, the influenza virus detection rate was 5.5% (152/2734), 4.8% (48/998), and 6.0% (104/1736) among individuals aged <5 and ≥5 years, respectively. The mean annual national number of influenza-associated SARI hospitalizations was 6181 (95% CI: 4321-8041-rate: 43.9; 95% CI: 30.7-57.1); 4669 (95% CI: 3287-6051-rate: 187.7; 95% CI: 132.1-243.3) among children aged <5 years; and 1512 (95% CI: 1037-1987-rate: 13.1; 95% CI: 9.0-17.2) among individuals aged ≥5 years.
The burden of influenza-associated SARI hospitalizations was substantial and was highest among children aged <5 years.
在中低收入国家,尤其是在非洲,对流感相关住院治疗的评估十分有限。
评估赞比亚全国因流感导致的严重急性呼吸道感染(SARI)住院治疗的人数。
我们在卢萨卡省的教学医院(UTH)开展了一项针对 SARI 的主动前瞻性医院监测,该监测于 2011-2014 年进行。采用逆转录酶聚合酶链反应检测上呼吸道样本中的流感病毒。我们根据世界卫生组织(WHO)推荐的评估方法,利用人口普查和呼吸道住院治疗的二次数据,对 UTH 的年龄特异性流感相关 SARI 住院治疗人数进行了评估。我们使用 UTH 的住院治疗率来估算卢萨卡省的流感相关 SARI 住院治疗率。根据肺炎相关风险因素和医疗服务利用情况,我们对其余 9 个省的住院治疗率进行了逐个调整。结果用每 10 万人中的病例数表示。
UTH 的呼吸道住院治疗患者中,SARI 占 77.1%(13389/17354);年龄<5 岁和≥5 岁患者中分别占 82.7%(11859/14344)和 50.8%(1530/3010)。在接受检测的 SARI 病例中,<5 岁和≥5 岁患者中流感病毒检出率分别为 5.5%(152/2734)、4.8%(48/998)和 6.0%(104/1736)。全国每年平均因流感导致的 SARI 住院治疗人数为 6181 例(95%CI:4321-8041-率:43.9;95%CI:30.7-57.1);年龄<5 岁儿童中为 4669 例(95%CI:3287-6051-率:187.7;95%CI:132.1-243.3);年龄≥5 岁患者中为 1512 例(95%CI:1037-1987-率:13.1;95%CI:9.0-17.2)。
流感相关 SARI 住院治疗负担沉重,<5 岁儿童的住院治疗负担最高。